Understanding how fluid drainage in the eye affects glaucoma treatments
Dynamic Variable Aqueous Humor Outflow and Glaucoma Therapies in the Human Eye
This study is looking at how fluid drains from the eye to help improve treatments for glaucoma, a condition that can cause vision loss, so that doctors can create personalized therapies that work better for each patient's unique eye needs.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10868428 on NIH RePORTER |
What this research studies
This research investigates the dynamic behavior of aqueous humor outflow in the eye, which is crucial for managing glaucoma, a leading cause of vision loss. By using advanced imaging techniques, the study aims to identify how and why the drainage of eye fluid can vary in different regions, potentially leading to improved treatment strategies. The goal is to develop personalized therapies that target specific areas of the eye where fluid drainage can be enhanced, thereby lowering intraocular pressure more effectively. Patients may benefit from tailored treatments based on their unique eye characteristics.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with glaucoma who are experiencing issues with intraocular pressure management.
Not a fit: Patients with glaucoma who have already undergone irreversible damage to their optic nerve may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatments for glaucoma, potentially preserving vision for many patients.
How similar studies have performed: Previous research has shown promise in understanding fluid dynamics in the eye, suggesting that this approach could lead to significant advancements in glaucoma treatment.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Huang, Alex — University of California, San Diego
- Study coordinator: Huang, Alex
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.